Fennec Pharmaceuticals (FENC) has the following price history information. Looking back at FENC historical stock prices for the last five trading days, on April 22, 2024, FENC opened at $9.34, traded as high as $9.48 and as low as $9.15, and closed at $9.38. Trading volume was a total of 165.50K shares. On April 23, 2024, FENC opened at $9.50, traded as high as $9.61 and as low as $9.05, and closed at $9.24. Trading volume was a total of 288.70K shares. On April 24, 2024, FENC opened at $9.18, traded as high as $9.30 and as low as $8.95, and closed at $9.07. Trading volume was a total of 182.10K shares. On April 25, 2024, FENC opened at $9.00, traded as high as $9.33 and as low as $8.83, and closed at $9.16. Trading volume was a total of 120.00K shares. On April 26, 2024, FENC opened at $9.15, traded as high as $9.30 and as low as $9.04, and closed at $9.21. Trading volume was a total of 154.30K shares.

FENC Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fennec Pharmaceuticals shares, starting with a $10,000 purchase of FENC, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	09/18/2017
End date:	04/26/2024
Start price/share:	$11.37
End price/share:	$9.21
Dividends collected/share:	$0.00
Total return:	-18.96%
Average Annual Total Return:	-3.13%
Starting investment:	$10,000.00
Ending investment:	$8,104.68
Years:	6.61

FENC Historical Price Range
Date	Open	High	Low	Close	Volume
04/22/2024	$9.34	$9.48	$9.15	$9.38	165.50K
04/23/2024	$9.50	$9.61	$9.05	$9.24	288.70K
04/24/2024	$9.18	$9.30	$8.95	$9.07	182.10K
04/25/2024	$9.00	$9.33	$8.83	$9.16	120.00K
04/26/2024	$9.15	$9.30	$9.04	$9.21	154.30K

About Fennec Pharmaceuticals

Fennec Pharmaceuticals is a biopharmaceutical company focused on its product candidate, PEDMARK® (sodium thiosulfate injection), which is used to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors. Co. has established Fennec HEARS™, a single source program designed to connect PEDMARK® patients to both patient financial and product access support. The program provides assistance and resources, regardless of insurance type, that can address co-pays or lack of coverage when certain eligibility requirements are met.

FENC Historical Closing Prices
Date	Close
04/22/2024	$9.38
04/23/2024	$9.24
04/24/2024	$9.07
04/25/2024	$9.16
04/26/2024	$9.21

FENC Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.